Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression

膳食多酚是基因表达的重要表观遗传调节剂

基本信息

  • 批准号:
    7434725
  • 负责人:
  • 金额:
    $ 36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-25 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): DNA methylation represents an important epigenetic mechanism that regulates a wide array of important biological processes. Abnormality in DNA methylation patterns is associated with various human disease conditions. In recent years, there has been a surge in research interest to address the potential modulating effect of various bioactive food components on DNA methylation, gene silencing, and reactivation. The overall objective of this application is aimed at providing systematic experimental evidence to establish a broad novel concept that many of the catecholic and noncatecholic polyphenols (e.g., tea catechins, bioflavonoids/isoflavonoids, coffee polyphenols) abundantly present in our daily diet constitute a major class of highly effective and consequential modulators of DNA methylation in vivo. This hypothesis is proposed on the basis of extensive preliminary data showing that dietary polyphenolic compounds can effectively modulate DNA methylation status in vitro and also in cultured cells. To achieve the goals, four broad-scoped but tightly-interlaced specific aims are planned to: 1) Determine in vitro inhibition of human DNMTs by various dietary polyphenols, and also study the kinetic mechanisms of human DNMT inhibition; 2) Conduct molecular modeling studies to determine the precise molecular mechanisms of human DNMT inhibition by active dietary polyphenols, and also to probe the structure-activity relationship of human DNMT inhibition by these dietary chemicals; 3) Study the effect of dietary polyphenols on DNA methylation and gene expression in human cancer cells grown in culture and in nude mice as xenografts; and 4) Study the effect of dietary polyphenols on DNA methylation, gene reactivation, and also on epigenetically-controlled phenotypes in mouse embryonic cells in culture and also in an intact animal model. It is expected that the outcomes of the proposed studies will have direct clinical utility in the near future and far-reaching human health implications.
描述(由申请人提供): DNA甲基化是一种重要的表观遗传学机制,它调控着一系列重要的生物学过程。DNA甲基化模式的异常与各种人类疾病有关。近年来,人们对各种生物活性食品成分对DNA甲基化、基因沉默和再激活的潜在调节作用的研究兴趣激增。本申请的总体目标旨在提供系统的实验证据以建立广泛的新概念,即许多儿茶酚和非儿茶酚多酚(例如,儿茶素、儿茶素/多酚、咖啡多酚)构成了体内DNA甲基化的主要一类高效和重要的调节剂。这一假说是基于大量的初步数据提出的,这些数据表明,膳食多酚化合物可以有效地调节体外和培养细胞中的DNA甲基化状态。为实现这一目标,本研究拟从四个方面展开:1)测定不同膳食多酚对人DNMT的体外抑制作用,并研究其抑制DNMT的动力学机制; 2)进行分子建模研究以确定活性膳食多酚抑制人DNMT的精确分子机制,3)研究膳食多酚对体外培养的人癌细胞和裸鼠移植瘤细胞DNA甲基化和基因表达的影响;和4)研究膳食多酚对培养的小鼠胚胎细胞和完整动物模型中的DNA甲基化、基因再活化以及表观遗传学控制的表型的影响。预计拟议研究的结果将在不久的将来具有直接的临床效用,并对人类健康产生深远的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BAO-TING ZHU其他文献

BAO-TING ZHU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BAO-TING ZHU', 18)}}的其他基金

Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
  • 批准号:
    7289336
  • 财政年份:
    2006
  • 资助金额:
    $ 36万
  • 项目类别:
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
  • 批准号:
    7645082
  • 财政年份:
    2006
  • 资助金额:
    $ 36万
  • 项目类别:
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
  • 批准号:
    7455988
  • 财政年份:
    2006
  • 资助金额:
    $ 36万
  • 项目类别:
2-METHOXYESTRADIOL & HORMONAL CANCER
2-甲氧基二醇
  • 批准号:
    6886982
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
Selective Induction of Estrogen Conjugative Metabolism
选择性诱导雌激素结合代谢
  • 批准号:
    7024997
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
2-METHOXYESTRADIOL & HORMONAL CANCER
2-甲氧基二醇
  • 批准号:
    6738045
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
Selective Induction of Estrogen Conjugative Metabolism
选择性诱导雌激素结合代谢
  • 批准号:
    6853607
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
2-METHOXYESTRADIOL & HORMONAL CANCER
2-甲氧基二醇
  • 批准号:
    6612121
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
2-METHOXYESTRADIOL & HORMONAL CANCER
2-甲氧基二醇
  • 批准号:
    7392631
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:
2-METHOXYESTRADIOL & HORMONAL CANCER
2-甲氧基二醇
  • 批准号:
    7054105
  • 财政年份:
    2003
  • 资助金额:
    $ 36万
  • 项目类别:

相似海外基金

Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
  • 批准号:
    10761217
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Development of brain-penetrant COMT inhibitors for the treatment of depressive disorders
开发用于治疗抑郁症的脑渗透性 COMT 抑制剂
  • 批准号:
    10696272
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Multidomain Peptide Hydrogels as a Therapeutic Delivery Platform for Cancer Treatment
多域肽水凝胶作为癌症治疗的治疗传递平台
  • 批准号:
    10743144
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Development of optoelectronically active nerve adhesive for accelerating peripheral nerve repair
开发用于加速周围神经修复的光电活性神经粘合剂
  • 批准号:
    10811395
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Combining Absolute Quantitative Cross-Linking Mass Spectrometry and Molecular Modeling for Probing PROTAC-Mediated Ternary Complex Structures
结合绝对定量交联质谱和分子建模来探测 PROTAC 介导的三元复杂结构
  • 批准号:
    10572720
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Fragment-based Discovery of COMT Inhibitors as a Novel Pharmacotherapy for Alcoholism
基于片段的 COMT 抑制剂的发现作为酒精中毒的新型药物疗法
  • 批准号:
    10667129
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
The Effects of Visit Characteristics on Patient-Clinician Interactions and Health Outcomes in Knee Osteoarthritis
就诊特征对膝骨关节炎患者与临床医生互动和健康结果的影响
  • 批准号:
    10735706
  • 财政年份:
    2023
  • 资助金额:
    $ 36万
  • 项目类别:
Nanostructured surfaces with improved hemocompatibility
具有改善血液相容性的纳米结构表面
  • 批准号:
    10686166
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
Broad spectrum β-lactamase inhibitors employing a Trojan horse mechanism to rescue β-lactams against multidrug-resistant Pseudomonas aeruginosa
广谱β-内酰胺酶抑制剂采用特洛伊木马机制来拯救β-内酰胺对抗多重耐药铜绿假单胞菌
  • 批准号:
    10482577
  • 财政年份:
    2022
  • 资助金额:
    $ 36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了